Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06137534
Other study ID # 08/2023
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 10, 2023
Est. completion date January 10, 2024

Study information

Verified date February 2024
Source Ege University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will be carried out with healthy students between the ages of 18-25 years who are studying at Ege University Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation and who voluntarily agree to participate in the study. Informed consent form will be signed before the evaluation of the individuals. The study will be carried out as a single group with the inclusion of a total of 20 individuals. The students who volunteered to participate in the study will actively apply the selected PNF upper extremity patterns for 4 weeks and will be evaluated twice, before and after the application. Demographic information of the individuals; age, height, weight, gender, background, surname, smoking habit, alcohol habit, education level (class), sports habit, COVID-19 disease status and when it occurred will be recorded. Cosmed pulmonary function test device will be used to evaluate the respiratory function of the individuals, Oncomed brand electronic body weight and height measurement device will be used to calculate the body mass index. Body Image Perception Scale will be used for body image perception, Beck Depression Inventory will be used to evaluate psychological status, and Rosenberg Self-Esteem Scale will be used to evaluate sense of self.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date January 10, 2024
Est. primary completion date November 10, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria: - Not diagnosed with any chronic disease - No neurological problems - Has not had COVID-19 for at least 6 months Exclusion Criteria: - Diagnosed with respiratory system diseases - Regular medication use - Suspected pregnancy - Individuals with rheumatic or neurological diseases

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Proprioceptive Neuromuscular Facilitation Upper Extremity Pattern
Proprioceptive neuromuscular facilitation upper extremity pattern exercises will be actively applied to 20 individuals in groups of 5 in a standing position for 30 minutes in each session 3 days a week for 4 weeks. PNF upper extremity patterns to be applied to the participants: Bilateral symmetrical flexion-adduction-external rotation. Bilateral symmetrical flexion-abduction-external rotation. Bilateral asymmetric right: flexion-abduction-external rotation, left: flexion-adduction-external rotation. Bilateral reciprocal (same diagonal) right: extension-adduction-internal rotation, left: flexion-abduction-external rotation. Bilateral reciprocal (same diagonal) right: flexion-adduction-external rotation, left: extension-abduction-internal rotation. Bilateral reciprocal (opposite diagonal) right: extension-adduction-internal rotation, left: flexion, adduction, external rotation.

Locations

Country Name City State
Turkey Ege University Izmir Karsiyaka

Sponsors (1)

Lead Sponsor Collaborator
Ege University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Forced vital capacity (FVC) It will be evaluated with Cosmed pulmonary function test device. The test will be performed according to the American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. The patient will be asked to take a deep breath in a sitting position and then exhale rapidly through the spirometer. Nasal clamp will be used during exhalation. At the beginning and at the end of 4 weeks of exercise.
Primary Forced expiratory volume in the first second (FEV1) It will be evaluated with Cosmed pulmonary function test device. The test will be performed according to the American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. The patient will be asked to take a deep breath in a sitting position and then exhale rapidly through the spirometer. Nasal clamp will be used during exhalation. At the beginning and at the end of 4 weeks of exercise.
Primary Forced expiratory volume in the first second/Forced vital capacity (FEV1/FVC) It will be evaluated with Cosmed pulmonary function test device. The test will be performed according to the American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. The patient will be asked to take a deep breath in a sitting position and then exhale rapidly through the spirometer. Nasal clamp will be used during exhalation. At the beginning and at the end of 4 weeks of exercise.
Primary Forced expiratory flow between 25% and 75% of vital capacity (FEF25-75) It will be evaluated with Cosmed pulmonary function test device. The test will be performed according to the American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. The patient will be asked to take a deep breath in a sitting position and then exhale rapidly through the spirometer. Nasal clamp will be used during exhalation. At the beginning and at the end of 4 weeks of exercise.
Primary Body Image Perception Scale The scale provides information about body image. The scale assesses satisfaction with 40 different body parts and functions. The scale has a minimum score of 40 and a maximum score of 200. A higher overall score on the scale indicates a higher negative judgement, while a lower overall score suggests a more positive evaluation. At the beginning and at the end of 4 weeks of exercise.
Secondary Rosenberg Self-Esteem Scale The scale consists of 63 items. It is evaluated over 12 subscales and it is accepted that those who score 0-1 on the self-esteem subscale have high self-esteem, those who score 2-4 have medium self-esteem and those who score 5-6 have low self-esteem. At the beginning and at the end of 4 weeks of exercise.
Secondary Beck Depression Inventory It is a scale developed to measure the behavioural findings of depression. As a result of the scoring, 0-9 points are interpreted as Minimal, 10-16 points as Mild, 17-29 points as Moderate, 30-63 points as Severe. At the beginning and at the end of 4 weeks of exercise.
See also
  Status Clinical Trial Phase
Completed NCT06044896 - Physiology of Body Lateralization on Regional Lung Ventilation Study N/A
Completed NCT02101801 - Urine Drug Levels Related to Source of Water for Irrigation for Vegetable Crops Among Healthy Israeli Volunteers N/A
Recruiting NCT06101641 - Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals N/A
Completed NCT03065283 - Effects of Diaphragm-releasing Techniques on the Lumbar Spine and Diaphragmatic Function in Healthy Women N/A
Recruiting NCT01721811 - Retinal Function in Relation to Transient or Chronic Challenges to Retinal Metabolism N/A
Completed NCT01211717 - The Effects of Orally Ingesting Branched Chained Amino Acids on Delayed Onset Muscle Soreness in Diabetic Patients N/A
Completed NCT01568541 - Fluoride Intake From Toothbrushig With Children's or Regular Toothpastes N/A
Completed NCT04941196 - Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition Phase 1
Completed NCT05541094 - Study of Vitamin D Fortification of Milk and Oil
Completed NCT05597657 - Normal Variation of T1 Values With Cardiac Magnetic Resonance in Healthy Individuals N/A
Completed NCT03728868 - Tolerability and Risk of Adverse Events With a Probiotic Supplement N/A
Recruiting NCT04513782 - The Contributions of Age Related Changes in the Sound Localization Pathway to Central Hearing Loss
Completed NCT05637060 - Bioequivalence Study of Rosuvastatin Tablet N/A
Not yet recruiting NCT05110885 - Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices
Completed NCT01134978 - Neural Mechanisms of the Contextual Interference Effect: A fNIRs and EEG Study Phase 1
Completed NCT04873570 - Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects Phase 1
Enrolling by invitation NCT01872091 - Analysis of Neuromuscular, Circulatory and Biomechanical Responses After Cryotherapy N/A
Completed NCT01872117 - Assessment of Temperature by Infrared Thermography and Blood Conduction Velocity by Doppler After Applying Shortwave Diathermy and Microwave - Correlations With Cardiovascular and Hemodynamic Parameters N/A
Completed NCT02409836 - A Study to Assess the Ingestion of Dentifrice by Children N/A
Recruiting NCT05358561 - Postprandial Glucose, Insulin and Subjective Saturation Response in Healthy Individuals N/A